Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.
Skip to main content
Fig. 2 | Perioperative Medicine

Fig. 2

From: Comparison of intravenous nalbuphine and dexmedetomidine in combination with lidocaine aerosol inhalation in awake direct laryngoscopy: a randomized, double-blind, placebo-controlled trial

Fig. 2

Changes in MAP (A), HR (B) and SpO2 (C) at different time points in the control group, Dex group and Nal group. *P < 0.017, **P < 0.001 vs. control group. #P < 0.017, ##P < 0.001 vs. Dex group. N.S.: no significant difference. MAP: mean arterial blood pressure; HR: heart rate; SpO2: peripheral oxygen saturation. The time points indicated in Fig. 4 are described as follows: T0 (before anesthesia), T1 (after anesthesia before ADL), T2 (immediately after ADL), and T3 (5 min after ADL)

Back to article page

Perioperative Medicine

ISSN: 2047-0525